Costco Wholesale Corporation vs Johnson & Johnson — how do they compare? Costco Wholesale Corporation trades at $946.92 (market cap $420.05B), while Johnson & Johnson trades at $261.44 (market cap $618.09B). The key difference: Johnson & Johnson is the larger of the two by market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Costco Wholesale Corporation for 133 Days and Johnson & Johnson for 129 Days on average.
| COST | JNJ | |
|---|---|---|
Market Cap | $420.05B | $618.09B |
Volume | 2,087,565 | 6,050,983 |
Sector | Consumer Staples | Health |
52-Week High | $1.09K | $278.43 |
52-Week Low | $849.63 | $186.00 |
Typical Hold Time | 133 Days | 129 Days |
Enterprise Value | $407.33B | $646.37B |
Dividend Yield | 0.62% | 2.09% |
Signals from Pluang's Aura AI — not financial advice
Costco (COST) trades at $947.92, up 0.6% with strong technical momentum. The stock shows robust fundamentals with revenue growth from $275.24B in 2025 to projected $303.2B in 2026 and improving net margins. Recent March sales surged 11.3% year-over-year, while analyst consensus remains strongly bullish with 66% buy ratings and a $1,100 price target. Technical indicators show bullish moving averages but overbought RSI levels near resistance at $954.
Outlook remains positive given membership fee increases and expansion potential, though high valuation multiples (P/E 45.66) pose risk if growth slows. Key risks include competitive pressures and economic sensitivity. Institutional accumulation continues with multiple advisors increasing positions in Q4 2025, supporting the bullish thesis.
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.
JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →